Leukemias and Lymphomas

• Acute Lymphoblastic Leukemia (ALL)
• Acute Myelogenous Leukemia (AML)
• Chronic Myelogenous Leukemia (CML)
• Chronic Lymphocytic Leukemia (CLL)
• Juvenile Chronic Myelogenous Leukemia
• Juvenile Myelomonocytic Leukemia
• Chronic Myelomonocytic Leukemia (CMML)

Stem Cell Disorders

• Aplastic Anemia (Severe)
• Fanconi Anemia

Myeloproliferative / Lymphoproliferative Disorders

• Acute Myelofibrosis
• Non-Hodgkin's Lymphoma
• Hodgkin's Disease

Phagocyte Disorders Inherited, Platelet Abnormalities, Other Malignancies

• Ewing Sarcoma
• Neuroblastoma
• Renal Cell Carcinoma
• Retinoblastoma

Inherited Metabolic Disorders

• Hurler's Syndrome (MPS-IH)
• Hunter's Syndrome (MPS-II)
• Mucolipidosis II (I-cell Disease)
• Krabbe Disease
• Gaucher's Disease
• Tay-Sachs

Plasma Cell Disorders

• Multiple Myleoma

Future Applications

• Cerebral Palsy
• Diabetes
• Heart Disease
• Multiple Sclerosis
• Muscular Dystrophy
• Parkinson's Disease
• Spinal Cord Injury
• Stroke
• Epidermolysis bullosa (rare genetic skin disease)

Again, these are partial listings under the major categories of diseases now treated as well as potential future applications. For a more detailed list contact us